New Lupus Research Highlights Heart Health
New research is offering another important reason for people living with lupus to have informed conversations with their healthcare providers about taking prescribed medications consistently.
A recent study examined the relationship between hydroxychloroquine (HCQ)—one of the most widely used treatments for systemic lupus erythematosus (SLE)—and cardiovascular risk. Researchers studied 248 adults with lupus, looking at hydroxychloroquine blood levels and longer-term medication use.
The researchers found that patients with very low HCQ blood levels and low long-term medication intake had higher estimated cardiovascular risk than patients with greater exposure to the medication. The findings add to growing research examining the relationship between lupus treatment and long-term heart health.
Why Heart Health Matters in Lupus
Lupus is a complex autoimmune disease that can affect many parts of the body, including the cardiovascular system. Understanding and managing cardiovascular risk can therefore be an important part of long-term lupus care.
Hydroxychloroquine has long been a foundational treatment for many people living with lupus. The new research provides another reason for patients and healthcare providers to discuss medication adherence, appropriate monitoring and cardiovascular health as part of an individualized treatment plan.
Turning Research Into Better Patient Conversations
Medication decisions should always be made in consultation with a qualified healthcare professional. Patients should not begin, stop or change the dosage of hydroxychloroquine—or any medication—based solely on the results of a research study.
At The Reid Foundation for Lupus®, we believe access to credible, understandable information can help people affected by lupus become better informed and more engaged in their healthcare. As research continues to advance our understanding of this complex disease, we will continue sharing developments that matter to the lupus community.
Source: Arthritis Care & Research / Yale School of Medicine.
